MENU
TNFA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
TNF Pharmaceuticals (TNFA) Ownership - Who owns TNF Pharmaceuticals?
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
4.02M
P/E Ratio
N/A
Total Cash
10.64M
Projected Growth
N/A
Total Debt
18.29K
Revenue
N/A
Risk (Beta)
2.59
Dividend Yield
N/A
Total Cash/Share
3.86
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
TNFA
Capitalization
4.02M
P/E Ratio
N/A
Risk (Beta)
2.59
Dividend Yield
N/A
Total Cash
10.6M
Total Cash/Share
3.86
Total Debt
18.3K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
16.6M
P/B Ratio
0.24
Cash Flow
N/A
Earnings
-13.54
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.47K
Current Ratio
1.72
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-11.38M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-126.08
Shares Held By Institutions
183K
Shares Outstanding - Current
2.76M
Total Liabilities
6.99M
Total Volume MTD
N/A
Value
1
Gain YTD
375.454
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information